Cargando…

Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasi

BACKGROUND: Patients with New World cutaneous leishmaniasis (NWCL) caused by Leishmania Viannia are treated with parenteral sodium stibogluconate (SbV) to reduce the risk of development of mucocutanous leishmaniasis. Our centre manages patients with NWCL on an outpatient-basis. This study was conduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wise, Emily S., Armstrong, Margaret S., Watson, Julie, Lockwood, Diana N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383730/ https://www.ncbi.nlm.nih.gov/pubmed/22745840 http://dx.doi.org/10.1371/journal.pntd.0001688

Ejemplares similares

Correction: Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasis
por: Wise, Emily S., et al.
Publicado: (2012)

Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination
por: Silva, Hermali, et al.
Publicado: (2021)

The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
por: Hussein, Nawfal R, et al.
Publicado: (2020)

Cutaneous leishmaniasis in a returned traveler
por: Kundu, Rupayan, et al.
Publicado: (2022)

Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial
por: Tilahun Zewdu, Feleke, et al.
Publicado: (2022)

Treatment of Cutaneous Leishmaniasis with Sodium Stibogluconate and Allopurinol in a Routine Setting in Ethiopia: Clinical and Patient-Reported Outcomes and Operational Challenges
por: van Henten, Saskia, et al.
Publicado: (2023)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2016)

Evaluating the Efficacy of Combined Intralesional Sodium Stibogluconate Plus Topical Imiquimod on Healing and Risk of Scarring of Cutaneous Leishmaniasis: A Case-Control Study
por: Dhaher, Samer A, et al.
Publicado: (2022)

Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell
por: Dar, M. Junaid, et al.
Publicado: (2018)

Cutaneous leishmaniasis and health-related quality of life in returning travellers to the UK
por: Peleva, Emilia, et al.
Publicado: (2020)

LEISHMANIASIS OF THE LIP DIAGNOSED BY LYMPH NODE ASPIRATION AND TREATED WITH A COMBINATION OF ORAL KETACONAZOLE AND INTRALESIONAL SODIUM STIBOGLUCONATE
por: Vasudevan, Biju, et al.
Publicado: (2011)

High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2014)

Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial
por: Musa, Ahmed, et al.
Publicado: (2012)

Leishmania major Cutaneous Leishmaniasis in 3 Travelers Returning from Israel to the Netherlands
por: Kuilder, Justin S., et al.
Publicado: (2016)

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
por: Kimutai, Robert, et al.
Publicado: (2017)

Transcriptional responses of Leishmania (Leishmania) amazonensis in the presence of trivalent sodium stibogluconate
por: Patino, Luz H., et al.
Publicado: (2019)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
por: Wasunna, Monique, et al.
Publicado: (2016)

A Randomized Controlled Trial of Local Heat Therapy Versus Intravenous Sodium Stibogluconate for the Treatment of Cutaneous Leishmania major Infection
por: Aronson, Naomi E., et al.
Publicado: (2010)

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
por: Solomon, Michal, et al.
Publicado: (2019)

Cutaneous Myiasis in Traveler Returning from Ethiopia
por: Hannam, Paul, et al.
Publicado: (2011)

Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK
por: Polley, Spencer D., et al.
Publicado: (2018)

Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia
por: Mengstie, Tiget Ayelgn, et al.
Publicado: (2021)

Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
por: Hodiamont, Caspar J., et al.
Publicado: (2014)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial
por: Omollo, Raymond, et al.
Publicado: (2011)

Cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis in 2 travelers
por: Achtman, Jordan C., et al.
Publicado: (2016)

Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia
por: Tamiru, Aschalew, et al.
Publicado: (2021)

False-positive rapid diagnostic test for malaria in new world cutaneous leishmaniasis: a tale of two travelers
por: Unterborn, Rebecca, et al.
Publicado: (2022)

Leg ulceration due to cutaneous melioidosis in a returning traveller
por: Stavrou, Christiana, et al.
Publicado: (2021)

Cutaneous Leishmaniasis in a Recreational Cave Diver After Travel to México
por: Siller Jr., Alfredo, et al.
Publicado: (2021)

Leishmania (Viannia) guyanensis Causing Localized Cutaneous Leishmaniasis in a Traveler
por: Motie, Ian K, et al.
Publicado: (2022)

Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers
por: Mouri, Oussama, et al.
Publicado: (2023)

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
por: Ramos, Guilherme S., et al.
Publicado: (2022)

Topical paromomycin for New World cutaneous leishmaniasis
por: Sosa, Néstor, et al.
Publicado: (2019)

A cluster of cutaneous larva migrans in travellers returning from Zanzibar
por: Korzeniewski, Krzysztof
Publicado: (2021)

Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice
por: Roychoudhury, Jayeeta, et al.
Publicado: (2011)

The Returning Traveller
por: Geddes, A.M., et al.
Publicado: (1981)

Pancytopenia due to proguanil toxicity in a returning traveller with fever
por: Jolink, Hetty, et al.
Publicado: (2010)

A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe
por: Haque, Lamia, et al.
Publicado: (2018)

Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
por: Yi, Taolin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u3v7c8v2vi79u92in1q1f75kf2